Table 8.
Risk-factor analysis before allo-BMT MR study results in ON-positive (n = 23) and ON-negative (n = 84) patients
| ON-positive [n (%)] |
ON-negative [n (%)]) |
Odds Ratio (95% CI) |
P value | |
|---|---|---|---|---|
| Gender | ||||
| Male | 10 (14.49) | 59 (85.51) | 0.02 | |
| Female | 13 (34.21) | 25 (65.79) | 3.07 (1.19, 7.92) | |
| Race | ||||
| Other | 3 (11.11) | 24 (88.89) | 0.28 | |
| Black | 5 (20.83) | 19 (79.17) | 2.11 (0.45, 9.95) | |
| White | 15 (26.79) | 41 (73.21) | 2.93 (0.77, 11.16) | |
| BMI at MR study 1 | ||||
| Normal | 9 (16.07) | 47 (83.93) | 0.65 | |
| Underweight | 2 (33.33) | 4 (66.67) | 2.61 (0.41, 16.46) | |
| Overweight | 5 (26.32) | 14 (73.68) | 1.87 (0.54, 6.48) | |
| Obese | 3 (18.75) | 13 (81.25) | 1.21 (0.28, 5.11) | |
| Age at MR study | ||||
| <10 | 3 (8.82) | 31 (91.18) | 0.04 | |
| ≥10 | 20 (27.40) | 53 (72.60) | 3.90 (1.07, 14.18) | |
| Age at Primary Diagnosis | ||||
| ≤2 | 2 (9.09) | 20 (90.91) | 0.27 | |
| 2 – 10 | 8 (21.62) | 29 (78.38) | 2.76 (0.53, 14.37) | |
| ≥10 | 13 (27.08) | 35 (72.92) | 3.71 (0.76, 18.15) | |
| Primary Diagnosis | ||||
| Others | 10 (16.13) | 52 (83.87) | 0.12 | |
| Lymphoid Malignancy & Aplastic Anemia |
13 (28.89) | 32 (71.11) | 2.11 (0.83, 5.38) |
| Multivariable analysis | ||
|---|---|---|
| Variable | Odds ratio (95%CI) | P value |
| Gender | ||
| Male (reference) | ||
| Female | 2.70 (1.00, 7.27) | 0.049 |
| Primary Diagnosis | ||
| Others (reference) | ||
| Lymphoid malignancies & Aplastic anemia |
2.72 (0.99, 7.48) | 0.053 |
| Age at MR study | ||
| ≥10 Years (reference) | ||
| ≥10 Years | 4.50 (1.16, 17.17) | 0.030 |
1
Data from patients younger than 2 and patients who did not have height/weight measured at MR date were not included.
Abbreviations: BMI, body mass index percentile; MR, magnetic resonance;